EV/EBITDA:
-19.10+0.37(+1.90%)Summary
- As of today, NAMS EV/EBITDA is -19.10, with a rise of +0.37 (+1.90%) during the most recent trading session on October 24, 2025.
- Over the past year, NAMS EV/EBITDA has dropped by -9.09 (-90.81%).
- NAMS EV/EBITDA is now -317.03% below its all-time high of -4.58.
Performance
NAMS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NAMS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +1.9% | -1.9% | -1.6% |
| 1M1 Month | -44.4% | +44.4% | +33.5% |
| 3M3 Months | -73.5% | +73.5% | +52.7% |
| 6M6 Months | -212.6% | +185.2% | +104.5% |
| YTDYTD | -71.6% | +69.0% | +39.0% |
| 1Y1 Year | -90.8% | +149.6% | +89.4% |
| 5Y5 Years | - | - | - |
NAMS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -12.92 | -47.8% | -22.19 | +13.9% |
| 3M | 3-Month | -9.64 | -98.1% | -22.19 | +13.9% |
| 6M | 6-Month | -5.84 | -227.1% | -22.19 | +13.9% |
| 1Y | 1-Year | -4.58 | -317.0% | -22.19 | +13.9% |
| 3Y | 3-Year | -4.58 | -317.0% | -284.06 | +93.3% |
| 5Y | 5-Year | -4.58 | -317.0% | -1189 | +98.4% |
| All-Time | All-Time | -4.58 | -317.0% | -1189 | +98.4% |
NAMS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -19.10(-71.6%) |
| 2024 | -11.13(+93.6%) |
| Date | Value |
|---|---|
| 2022 | -174.80(-72.8%) |
| 2021 | -101.16 |
FAQ
- What is NewAmsterdam Pharma Company N.V. EV/EBITDA?
- What is the all-time high EV/EBITDA for NewAmsterdam Pharma Company N.V.?
- What is NAMS EV/EBITDA year-to-date change?
- What is NewAmsterdam Pharma Company N.V. EV/EBITDA year-on-year change?
What is NewAmsterdam Pharma Company N.V. EV/EBITDA?
The current EV/EBITDA of NAMS is -19.10
What is the all-time high EV/EBITDA for NewAmsterdam Pharma Company N.V.?
NewAmsterdam Pharma Company N.V. all-time high EV/EBITDA is -4.58
What is NAMS EV/EBITDA year-to-date change?
NewAmsterdam Pharma Company N.V. EV/EBITDA has changed by -7.97 (-71.61%) since the beginning of the year
What is NewAmsterdam Pharma Company N.V. EV/EBITDA year-on-year change?
Over the past year, NAMS EV/EBITDA has changed by -9.09 (-90.81%)